IP Library Granted Patent US 10,143,555
Granted Patent B2
US 10,143,555 · App. 14/815,348 · Granted Dec 4, 2018

Customized implants for bone replacement

Inventors: Scott DeFelice (Holyoke, MA); Anthony DeCarmine (Lebanon, CT)
Assignee: Oxford Performance Materials, LLC
A61F2/30771A61F2/28A61F2/30942A61L27/165A61L27/54A61L27/56B29C64/153B33Y80/00A61F2002/3092A61F2002/3093A61F2002/3097A61F2002/30774A61F2002/30784A61F2002/30838A61F2002/30948A61F2002/30952A61F2002/30962A61F2002/30968A61F2240/002A61L2300/602A61L2430/02B29K2071/00B29L2031/7532
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,143,555
App. No.
14/815,348
Granted
Dec 4, 2018
Kind
B2
Abstract

The present invention relates to customized implants for bone replacement that are prepared from poly(ether ketone ketone) or PEKK, and to a computer-based imaging and rapid prototyping (RP)-based manufacturing method for the design and manufacture of these customized implants. The PEKK customized implants made using rapid prototyping demonstrate biomechanical properties similar (if not identical) to that of natural bone even when prepared without the use of processing aids such as carbon black and aluminum powder.

Claims (29)

1. An implant or scaffold for bone replacement composed exclusively of pure selectively laser sintered poly(ether ketone ketone) (PEKK), the implant or scaffold being capable of ongrowth/ingrowth of tissues, the implant or scaffold not comprising calcium phosphate.

2. An implant or scaffold for bone replacement, comprising laser sintered poly(ether ketone ketone) (PEKK), the implant or scaffold being capable of ongrowth/ingrowth of tissues, the implant or scaffold not comprising calcium phosphate.

3. The implant or scaffold of claim 2 , further at least one feature selected from the group consisting of a) openings configured to encourage bone, vascular and nerve in-growth, b) surface pores configured to hold therapeutic agents, and c) surface anchors and/or threaded holes.

4. The implant or scaffold of claim 3 , wherein said surface pores hold one or more therapeutic agents selected from the group consisting of antibiotics, anti-coagulants, anti-inflammatory, anti-metabolites, antivirals, bone morphogenic proteins, cell adhesion molecules, growth factors, healing promoters, immunosuppressants, vascularizing agents, and topical anesthetics/analgesics; said therapeutic agents optionally being present in or on a carrier for controlled release.

5. The implant or scaffold of claim 4 , wherein said carrier is encapsulated in a biocompatible or biodegradable polymer, or in a bioadhesive gel.

6. The implant or scaffold of claim 1 , comprising a rigid implant having an inner core with a low porosity of 10 percent or less pores and an outer layer, said implant having a compressive strength ASTM #D695 of from 100 to 200 megapascals (Mpa) and a flexural modulus ASTM #D570 of greater than 3.5 gigapascals (GPa).

7. The implant or scaffold of claim 6 , wherein said implant replaces a load-bearing bone.

8. The implant or scaffold of claim 7 , wherein said load-bearing bone is selected from a spine, a long bone of an arm or a leg, and a hip bone.

9. The implant or scaffold of claim 8 , wherein at least 95 percent of pores have a diameter of 1-500 microns.

10. The implant or scaffold of claim 1 , comprising a substantially uniform cross-sectional morphology having a porosity of greater than about 35 percent, wherein the pores are interconnected and have an average diameter of 50-250 microns, and wherein said implant or scaffold has a compressive strength ASTM #D695 of from 10 to 200 megapascals (Mpa) and a flexural modulus ASTM #D570 of from 0.5 to 4.5 gigapascals (GPa).

11. The implant or scaffold of claim 10 , comprising a bone replacement scaffolding for ongrowth/ingrowth of tissues, or as a support for stem cells.

12. An implant or scaffold comprising a laser sintered composition comprising pure poly(ether ketone ketone) (PEKK) the implant or scaffold not comprising calcium phosphate, wherein said powder has an average particle size of from 10-150 microns, and is either a) semi-crystalline, having at least 10% crystallinity by weight as measured by DSC, or said powder is b) quasi-amorphous, at most 2% crystallinity as measured by DSC.

13. The implant or scaffold of claim 10 , comprising a three-dimensional lattice structure having a plurality of bars crossing each other in a plurality of zones, the bars being fused in each of the zones, wherein the interstitial spaces between adjacent bars define a plurality of interconnected pores or channels in the lattice structure.

14. An implant or scaffold comprising a laser sintered composition composed exclusively of pure poly(ether ketone ketone) (PEKK) powder, the implant or scaffold not comprising calcium phosphate, wherein said powder has an average particle size of from 10-150 microns, and is either a) semi-crystalline, having at least 10% crystallinity by weight as measured by DSC, or said powder is b) quasi-amorphous, at most 2% crystallinity as measured by DSC.

15. The laser sinterable composition of claim 12 , wherein said composition further comprises one or more fillers selected from the group consisting of glass, carbon, mineral fillers, surface-bioactive ceramics, solids that will render the implant or scaffold radioopaque, and barium sulfate (BaSO 4 ).

16. The laser sinterable composition of claim 14 , wherein said powder has an average particle size of from 20-100 microns.

17. The laser sinterable composition of claim 14 wherein said semi-crystalline powder has 15-90% crystallinity as measured by DSC.

18. The laser sinterable composition of claim 14 , wherein said powder has an average particle size of from 50-70 microns.

19. The laser sinterable composition of claim 14 wherein said semi-crystalline powder has 15-35% crystallinity as measured by DSC.

20. A process for producing a customized implant or scaffold for bone replacement comprising the steps of:

(a) scanning a patient in an area requiring bone repair or replacement to obtain tomographic information;

(b) designing a bone implant model using computer aided design from the tomographic information obtained from the patient;

(c) optionally, modifying the bone implant model by one or more of the following steps: adding suture anchors, threaded holes, mating surfaces and textures, open cell regions for scaffolding, surface pores to carry antibiotics, and/or varying density or porosity levels so as to vary stiffness or rigidity; and

(d) forming a bone implant or scaffold using a solid free-form fabrication method from the bone implant model, the bone implant being composed of sequential layers of biocompatible pure laser sintered poly(ether ketone ketone) (PEKK) powder, said implant or scaffold being capable of ongrowth/ingrowth of tissues said implant or scaffold not comprising calcium phosphate.

21. The process of claim 20 , wherein said fabrication method in step (d) is by selective laser sintering (SLS).

22. The process of claim 20 , wherein the PEKK powder has an average particle size of from 10 to 150 microns.

23. The process of claim 20 , wherein said PEKK powder further comprises from 5 to 40 weight percent of additives, based on the weight of PEKK.

24. The process of claim 23 , wherein said additives are selected from the group consisting of solids to render the implant or scaffold radioopaque.

25. The implant or scaffold of claim 1 , wherein the implant or scaffold has openings to encourage bone, vascular, and nerve growth.

Assignments (3)
SECURITY INTEREST Recorded Mar 13, 2026
From: OXFORD PERFORMANCE MATERIALS, INC.
To: KENSTON CAPITAL EMERGING TECHNOLOGY FUND I LP
Reel/Frame 074077/0347 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jan 16, 2019
From: OXFORD PERFORMANCE MATERIALS, INC.
To: WEBSTER BANK, NATIONAL ASSOCIATION
Reel/Frame 048082/0373 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 19, 2016
From: DEFELICE, SCOTT; DECARMINE, ANTHONY
To: OXFORD PERFORMANCE MATERIALS, INC.
Reel/Frame 038322/0096 →
Continuity (3)
Continuation 13058905
Provisional Application 61088838 · Aug 14, 2008
Related Publication 20150351915A1 · Dec 10, 2015
Cited By (2)
US 12,462,916 US 12,487,579